Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Contact

Karl Frisch, 202-580-5813

Press Release

REPORT: As Senate Democrats Eye Medicare Rx Drug Negotiation Authority, Big Pharma Has Already Spent $147M Lobbying Against Lower Drug Prices During Pandemic While Posting Record Profits

WASHINGTON -

Ahead of the U.S. Labor Department’s Consumer Price Index report and as Senate Democrats consider giving Medicare authority to negotiate lower prescription prices as part of their reconciliation package, a new analysis from corporate watchdog Accountable.US found PhRMA and the top five drug companies have spent at least $147 million lobbying against lowering drug prices since the start of the pandemic. The pharmaceutical industry known for charging seniors an arm and leg for their medicines is now poised to unleash another major lobbying offensive against the Democratic reconciliation deal, as they did against the sweeping drug pricing proposals in H.R. 3, so they can keep raising prices to absurd degrees without justification.

Additionally, Accountable.US found major drug company CEOs have raked in over $292.6 million in compensation while their companies saw skyrocketing profits – at a time Americans spend an average of $1,200 per person on Rx drugs and as many as 18 million Americans simply cannot afford their prescribed medications. 

“Big Pharma, like many other industries, knows they cannot justify raising prices so high at the same time they boast of excessive profits, generous CEO bonuses and huge shareholder payouts. That is why the big drug companies spend so massively lobbying to keep the market rigged in their favor and seniors at their mercy, including many literally choosing between food and medicine. It is time the conservatives in Congress who complain constantly about inflation finally do something constructive about it -- and there’s no better place to start than allowing Medicare to finally negotiate lower drug prices. What really matters most to these lawmakers: bringing down costs for seniors, or looking out for the bottom line of their big drug company donors?” --Accountable.US spokesperson Liz Zelnick

 

Accountable.US previously found Republican lawmakers on the House Energy & Commerce Committee who voted against allowing Medicare to negotiate the prices of prescription drugs with drug companies (H.R. 3) have taken nearly $1.7 million in career contributions from industry groups and the five largest pharmaceutical companies opposed to Medicare drug negotiations. The new analysis follows Accountable.US’ research over the last several months on how runaway corporate greed from the big oil, meat packing, shipping, retail, clothing, food, trucking and railroad companies has been making inflation challenges much worse for everyday consumers. 

###

Accountable.US is a nonpartisan watchdog that exposes corruption in public life and holds government officials and corporate special interests accountable by bringing their influence and misconduct to light. In doing so, we make way for policies that advance the interests of all Americans, not just the rich and powerful. 

$158,000 Cost for ALS Treatment Called 'A Poster Child' for Unjust Drug Pricing

"The price of the newly approved drug combination Relyvrio to treat ALS," said one critic, "is yet another clear and powerful example of unjustified high prices set by drug companies that ultimately exploit patients."

Jake Johnson ·


Biden Takes 'Important First Step' With AI Bill of Rights Blueprint

While many experts welcomed the White House proposal to ensure automated systems don't erode civil liberties, others lamented the voluntary nature of what one tech writer called the "toothless" plan.

Brett Wilkins ·


The Onion Files 'Masterfully Written' Amicus Brief in Support of Jailed Parodist

"As the globe's premier parodists, The Onion's writers also have a self-serving interest in preventing political authorities from imprisoning humorists."

Brett Wilkins ·


Jayapal Accuses Democratic Leaders of Botching Stock Trading Ban

"This should have been a no-brainer," said the Washington Democrat.

Julia Conley ·


Climate Coalition Pushes Social Media CEOs to End Planet-Killing Disinformation

"Platforms owe it to their users and the planet to stop amplifying the climate disinformation that undermines our ability to combat the climate crisis."

Jake Johnson ·

Common Dreams Logo